Methods for drug safety signal detection using routinely collected observational electronic health care data: A systematic review

被引:11
|
作者
Coste, Astrid [1 ]
Wong, Angel [1 ]
Bokern, Marleen [1 ]
Bate, Andrew [1 ,2 ]
Douglas, Ian J. [1 ]
机构
[1] LSHTM, Dept Noncommunicable Dis Epidemiol, London, England
[2] Global Safety, Brentford, England
关键词
drug safety surveillance; pharmacoepidemiology; pharmacovigilance; real world data; signal detection; systematic review; CONTROLLED CASE SERIES; SPONTANEOUS REPORTING DATABASE; SEQUENCE SYMMETRY ANALYSIS; LONGITUDINAL DATABASES; EMPIRICAL-ASSESSMENT; RISK IDENTIFICATION; ADVERSE EVENTS; SURVEILLANCE; CLAIMS; RECORDS;
D O I
10.1002/pds.5548
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose Signal detection is a crucial step in the discovery of post-marketing adverse drug reactions. There is a growing interest in using routinely collected data to complement established spontaneous report analyses. This work aims to systematically review the methods for drug safety signal detection using routinely collected healthcare data and their performance, both in general and for specific types of drugs and outcomes. Methods We conducted a systematic review following the PRISMA guidelines, and registered a protocol in PROSPERO. MEDLINE, EMBASE, PubMed, Web of Science, Scopus, and the Cochrane Library were searched until July 13, 2021. Results The review included 101 articles, among which there were 39 methodological works, 25 performance assessment papers, and 24 observational studies. Methods included adaptations from those used with spontaneous reports, traditional epidemiological designs, methods specific to signal detection with real-world data. More recently, implementations of machine learning have been studied in the literature. Twenty-five studies evaluated method performances, 16 of them using the area under the curve (AUC) for a range of positive and negative controls as their main measure. Despite the likelihood that performance measurement could vary by drug-event pair, only 10 studies reported performance stratified by drugs and outcomes, in a heterogeneous manner. The replicability of the performance assessment results was limited due to lack of transparency in reporting and the lack of a gold standard reference set. Conclusions A variety of methods have been described in the literature for signal detection with routinely collected data. No method showed superior performance in all papers and across all drugs and outcomes, performance assessment and reporting were heterogeneous. However, there is limited evidence that self-controlled designs, high dimensional propensity scores, and machine learning can achieve higher performances than other methods.
引用
收藏
页码:28 / 43
页数:16
相关论文
共 48 条
  • [1] Use of routinely collected electronic healthcare data for postlicensure vaccine safety signal detection: a systematic review
    Mesfin, Yonatan Moges
    Cheng, Allen
    Lawrie, Jock
    Buttery, Jim
    BMJ GLOBAL HEALTH, 2019, 4 (04):
  • [2] Using Electronic Health Care Records for Drug Safety Signal Detection A Comparative Evaluation of Statistical Methods
    Schuemie, Martijn J.
    Coloma, Preciosa M.
    Straatman, Huub
    Herings, Ron M. C.
    Trifiro, Gianluca
    Matthews, Justin Neil
    Prieto-Merino, David
    Molokhia, Mariam
    Pedersen, Lars
    Gini, Rosa
    Innocenti, Francesco
    Mazzaglia, Giampiero
    Picelli, Gino
    Scotti, Lorenza
    van der Lei, Johan
    Sturkenboom, Miriam C. J. M.
    MEDICAL CARE, 2012, 50 (10) : 890 - 897
  • [3] Epidemiology of major lower limb amputation using routinely collected electronic health data in the UK: a systematic review protocol
    Meffen, Anna
    Pepper, Coral J.
    Sayers, Robert D.
    Gray, Laura J.
    BMJ OPEN, 2020, 10 (06):
  • [4] The validity of dementia diagnoses in routinely collected electronic health records in the United Kingdom: A systematic review
    McGuinness, Luke A.
    Warren-Gash, Charlotte
    Moorhouse, Louisa R.
    Thomas, Sara L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 (02) : 244 - 255
  • [5] Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD
    Schuemie, Martijn J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (03) : 292 - 299
  • [6] Methods for evaluating the benefit and harms of deprescribing in observational research using routinely collected data
    Moriarty, Frank
    Thompson, Wade
    Boland, Fiona
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2022, 18 (02) : 2269 - 2275
  • [7] Evaluation of reporting quality for observational studies using routinely collected health data in pharmacovigilance
    Nie, Xiaolu
    Zhang, Ying
    Wu, Zehao
    Jia, Lulu
    Wang, Xiaoling
    Langan, Sinead M.
    Benchimol, Eric I.
    Peng, Xiaoxia
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (07) : 661 - 668
  • [8] Case-finding for common mental disorders in primary care using routinely collected data: a systematic review
    Larvin, Harriet
    Peckham, Emily
    Prady, Stephanie L.
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2019, 54 (10) : 1161 - 1175
  • [9] Case-finding for common mental disorders in primary care using routinely collected data: a systematic review
    Harriet Larvin
    Emily Peckham
    Stephanie L. Prady
    Social Psychiatry and Psychiatric Epidemiology, 2019, 54 : 1161 - 1175
  • [10] Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review
    Davis, Sharon E.
    Zabotka, Luke
    Desai, Rishi J.
    Wang, Shirley, V
    Maro, Judith C.
    Coughlin, Kevin
    Hernandez-Munoz, Jose J.
    Stojanovic, Danijela
    Shah, Nigam H.
    Smith, Joshua C.
    DRUG SAFETY, 2023, 46 (08) : 725 - 742